estriol has been researched along with Acrania in 46 studies
hormonin: estrogen replacement; each tablet contains 600 ug micronized 17beta-estradiol, 270 ug estriol and 1.4 mg estrone
chlorapatite : A phosphate mineral with the formula Ca5(PO4)3Cl.
| Excerpt | Relevance | Reference |
|---|---|---|
| "BACKGROUND We aimed to insure the accuracy and reproducibility of alpha-fetoprotein (AFP), free beta-human chorionic gonadotropin (free ß-hCG), and unconjugated estriol (uE3) concentrations for the screening for trisomy 21 (T21) and neural tube defects (NTD) in the second trimester." | 8.12 | External Quality Assessment of Maternal Serum Levels of Alpha-Fetoprotein, Free Beta-Human Chorionic Gonadotropin, and Unconjugated Estriol in Detecting Down Syndrome and Neural Tube Defects in the Second Trimester of 87 Maternal Serum Samples, Based on 1 ( Chen, Y; Li, L; Ning, W; Shi, Y; Wang, X; Zhang, H, 2022) |
| "To assess the value of alpha-fetoprotein (AFP), total human chorionic gonadotropin (ThCG) and unconjugated estriol in predicting certain complications of pregnancy other than fetal aneuploidy." | 7.72 | Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy. ( Duric, K; Kalafatic, D; Kuvacic, I; Lesin, J; Skrablin, S; Suchanek, E, 2003) |
| "BACKGROUND We aimed to insure the accuracy and reproducibility of alpha-fetoprotein (AFP), free beta-human chorionic gonadotropin (free ß-hCG), and unconjugated estriol (uE3) concentrations for the screening for trisomy 21 (T21) and neural tube defects (NTD) in the second trimester." | 4.12 | External Quality Assessment of Maternal Serum Levels of Alpha-Fetoprotein, Free Beta-Human Chorionic Gonadotropin, and Unconjugated Estriol in Detecting Down Syndrome and Neural Tube Defects in the Second Trimester of 87 Maternal Serum Samples, Based on 1 ( Chen, Y; Li, L; Ning, W; Shi, Y; Wang, X; Zhang, H, 2022) |
| "Between November, 2011 and October, 2013, a total of 25 520 pregnant women (15-20+6 gestational weeks) underwent a screening test of triple serum markers including free beta-human chorionic gonadotrophin (free βhCG), alpha-fetoprotein (AFP), and unconjugated estriol (µE3) during the second semester of pregnancy." | 3.81 | [Serum marker screening during the second trimester for prenatal diagnosis and predicting pregnancy outcome]. ( Jiang, J; Liu, J; Tao, H; Wang, J; Wu, J; Yang, L; Zhao, L, 2015) |
| "Second trimester serum levels of alpha-fetoprotein (AFP), human chorionic gonadotrophin (hCG), and unconjugated estriol were compared for 306 CHD cases and 1224 no-CHD controls drawn from a sample of singleton pregnancies without chromosomal or neural tube defects (NTDs)." | 3.77 | Second trimester serum predictors of congenital heart defects in pregnancies without chromosomal or neural tube defects. ( Baer, R; Currier, RJ; Jelliffe-Pawlowski, L; Moon-Grady, AJ, 2011) |
| " Serum analytes (pregnancy associated plasma protein A [PAPP-A], hCG, creatinine [Cr], and alanine aminotransferase [ALT]) were drawn at approximately 12 weeks' gestation, and alpha-fetoprotein and unconjugated estriol were drawn at 16 weeks' gestation." | 3.77 | Effect of mild hepatic or renal impairment on maternal serum screening biochemical measures. ( Nisenbaum, R; Ray, JG; Wyatt, PR; Ying, I, 2011) |
| "To assess the value of alpha-fetoprotein (AFP), total human chorionic gonadotropin (ThCG) and unconjugated estriol in predicting certain complications of pregnancy other than fetal aneuploidy." | 3.72 | Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy. ( Duric, K; Kalafatic, D; Kuvacic, I; Lesin, J; Skrablin, S; Suchanek, E, 2003) |
| "Maternal serum screening (MSS) measures three serum markers: alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol, from which the risk of fetal Down syndrome or open neural tube defect is calculated." | 3.69 | Maternal serum screening. ( Carroll, JC, 1994) |
| "5 multiples of the median] and Down syndrome [risk > or = 1/274 using MSAFP, maternal serum unconjugated oestriol (MSuE3), maternal serum human chorionic gonadotropin (MShCG), and maternal age]." | 3.69 | Adverse perinatal outcome in patients screen-positive for neural tube defects and fetal Down syndrome. ( Bright, NL; Dungan, JS; Elias, S; Gross, SJ; Phillips, OP; Shulman, LP; Simpson, JL, 1994) |
| "This study examines the relationship between maternal weight and serum levels of alpha-fetoprotein, unconjugated oestriol, and human chorionic gonadotropin in a population of 47,585 women being provided with prenatal screening for Down's syndrome and open neural tube defects." | 3.69 | Refinements in managing maternal weight adjustment for interpreting prenatal screening results. ( Haddow, JE; Knight, GJ; Larrivee, DA; Neveux, LM; Palomaki, GE, 1996) |
| "The risk of fetal trisomy 21 was calculated with the use of PRISCA 3." | 2.69 | Analysis of triple test results in 27 cases of twin pregnancies. ( Dudarewicz, L; Kałuzewski, B; Perenc, M, 1998) |
| "The DR and SPR for trisomy 21 (N = 827) during the quadruple-marker time period were 75." | 1.37 | Detection rate of quadruple-marker screening determined by clinical follow-up and registry data in the statewide California program, July 2007 to February 2009. ( Currier, RJ; Flessel, M; Goldman, S; Hennigan, C; Hodgkinson, C; Kazerouni, NN; Lorey, F; Malm, L; Roberson, M; Tempelis, C, 2011) |
| "Follow-up of all cases of chromosome abnormalities and severe foetal malformations identified pre- or postnatally has been carried out." | 1.30 | [Maternal serum screening for congenital abnormalities and Down syndrome in Sønderjylland County. Eight years of experience]. ( Christiansen, M; Larsen, LA; Nørgaard-Pedersen, B; Permin, M; Petersen, PL, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 20 (43.48) | 18.2507 |
| 2000's | 17 (36.96) | 29.6817 |
| 2010's | 8 (17.39) | 24.3611 |
| 2020's | 1 (2.17) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y | 2 |
| Shi, Y | 1 |
| Ning, W | 1 |
| Wang, X | 1 |
| Li, L | 2 |
| Zhang, H | 1 |
| Xu, L | 1 |
| Huang, H | 1 |
| Zheng, L | 1 |
| He, D | 1 |
| Lin, N | 1 |
| Wang, L | 1 |
| Lin, Y | 1 |
| Hu, Z | 1 |
| Liu, X | 1 |
| Jia, C | 1 |
| Li, D | 1 |
| Liu, R | 1 |
| Yang, L | 1 |
| Zhao, L | 1 |
| Jiang, J | 1 |
| Liu, J | 1 |
| Tao, H | 1 |
| Wang, J | 1 |
| Wu, J | 1 |
| Salazar López, R | 1 |
| Ibarra Gallardo, AL | 1 |
| Iduma Meléndrez, M | 1 |
| Leyva Bojórquez, R | 1 |
| Pekarek, DM | 1 |
| Chapman, VR | 1 |
| Neely, CL | 1 |
| Ramsey, PS | 1 |
| Biggio, JR | 1 |
| Jelliffe-Pawlowski, L | 1 |
| Baer, R | 1 |
| Moon-Grady, AJ | 1 |
| Currier, RJ | 2 |
| Kazerouni, NN | 1 |
| Flessel, M | 1 |
| Goldman, S | 1 |
| Hennigan, C | 1 |
| Hodgkinson, C | 1 |
| Lorey, F | 1 |
| Malm, L | 1 |
| Tempelis, C | 1 |
| Roberson, M | 2 |
| Peled, Y | 1 |
| Melamed, N | 1 |
| Krissi, H | 1 |
| Eitan, R | 1 |
| Yogev, Y | 1 |
| Pardo, J | 1 |
| Ying, I | 1 |
| Wyatt, PR | 4 |
| Nisenbaum, R | 1 |
| Ray, JG | 1 |
| Hui, D | 1 |
| Okun, N | 1 |
| Murphy, K | 1 |
| Kingdom, J | 1 |
| Uleryk, E | 1 |
| Shah, PS | 1 |
| Chitayat, D | 1 |
| Farrell, SA | 2 |
| Huang, T | 4 |
| Meier, C | 3 |
| Summers, AM | 4 |
| Duric, K | 1 |
| Skrablin, S | 1 |
| Lesin, J | 1 |
| Kalafatic, D | 1 |
| Kuvacic, I | 1 |
| Suchanek, E | 1 |
| Alberman, E | 1 |
| Wald, N | 1 |
| Owolabi, T | 1 |
| Serdar, MA | 1 |
| Tütüncü, L | 1 |
| Olgun, A | 1 |
| Haşimi, A | 1 |
| Ozgurtaş, T | 1 |
| Erbil, MK | 1 |
| Husseini, A | 1 |
| Akkawi, M | 1 |
| Craig, WY | 1 |
| Haddow, JE | 2 |
| Palomaki, GE | 3 |
| Holzgreve, W | 1 |
| Miny, P | 1 |
| Schloo, R | 1 |
| Tercanli, S | 1 |
| Carroll, JC | 1 |
| Gross, SJ | 1 |
| Phillips, OP | 1 |
| Shulman, LP | 1 |
| Bright, NL | 1 |
| Dungan, JS | 1 |
| Simpson, JL | 1 |
| Elias, S | 2 |
| van den Boer-van den Berg, JM | 1 |
| Dupuis, HM | 1 |
| Rose, NC | 1 |
| Mennuti, MT | 1 |
| Wildhagen, MF | 1 |
| Christiaens, GC | 2 |
| Habbema, JD | 1 |
| Mennuti, M | 1 |
| Yankowitz, J | 1 |
| Howser, DM | 1 |
| Ely, JW | 1 |
| Wilkins-Haug, L | 1 |
| Horton, JA | 1 |
| Cruess, DF | 1 |
| Frigoletto, FD | 1 |
| Neveux, LM | 1 |
| Larrivee, DA | 1 |
| Knight, GJ | 1 |
| Ross, HL | 1 |
| Benn, PA | 1 |
| Borgida, A | 1 |
| Horne, D | 1 |
| Briganti, S | 1 |
| Collins, R | 1 |
| Rodis, JF | 1 |
| Frishman, GN | 1 |
| Canick, JA | 4 |
| Hogan, JW | 1 |
| Hackett, RJ | 1 |
| Kellner, LH | 1 |
| Saller, DN | 1 |
| Yaron, Y | 1 |
| Hamby, DD | 1 |
| O'Brien, JE | 1 |
| Critchfield, G | 1 |
| Leon, J | 1 |
| Ayoub, M | 1 |
| Johnson, MP | 1 |
| Evans, MI | 1 |
| van Rijn, M | 1 |
| van der Schouw, YT | 1 |
| Hagenaars, AM | 1 |
| de Pater, JM | 1 |
| Visser, GH | 1 |
| Bao, P | 1 |
| Wu, Y | 1 |
| Gu, Q | 1 |
| Christiansen, M | 1 |
| Petersen, PL | 1 |
| Permin, M | 1 |
| Larsen, LA | 1 |
| Nørgaard-Pedersen, B | 1 |
| Rausch, DN | 2 |
| Lambert-Messerlian, GM | 3 |
| Perenc, M | 1 |
| Dudarewicz, L | 1 |
| Kałuzewski, B | 1 |
| Cuckle, H | 1 |
| Onda, T | 1 |
| Tanaka, T | 1 |
| Yoshida, K | 1 |
| Nakamura, Y | 1 |
| Kudo, R | 1 |
| Yamamoto, H | 1 |
| Sato, A | 1 |
| Yanagida, K | 1 |
| Takai, Y | 1 |
| Uemura, H | 1 |
| Hoshi, K | 1 |
| Fukada, Y | 1 |
| Miyake, Y | 1 |
| Ohnishi, M | 1 |
| Kaneoka, T | 1 |
| Makino, Y | 1 |
| Murata, Y | 1 |
| Kanzaki, T | 1 |
| Kanzaki, H | 1 |
| Osaki, T | 1 |
| Aono, T | 1 |
| Maeda, K | 1 |
| Ogita, S | 1 |
| Yamamasu, S | 1 |
| Aso, T | 1 |
| Shimizu, Y | 2 |
| Izutsu, T | 1 |
| Kudo, T | 1 |
| Okai, T | 1 |
| Sakai, M | 1 |
| Hashimoto, T | 1 |
| Matsuzaki, N | 1 |
| Kitagawa, M | 1 |
| Sago, H | 1 |
| Grier, RE | 1 |
| Myrick, F | 1 |
| Akbas, SH | 1 |
| Ozben, T | 1 |
| Alper, O | 1 |
| Ugur, A | 1 |
| Yücel, G | 1 |
| Lüleci, G | 1 |
| Graves, JC | 1 |
| Miller, KE | 1 |
| Sellers, AD | 1 |
| Kostiuk, EV | 1 |
| Zolotukhina, TV | 1 |
| Kuznetsov, MI | 1 |
| Cuckle, HS | 1 |
| Wald, NJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Early Prediction Of Preterm Delivery By Measurement Of Maternal Serum Markers[NCT01009723] | 2,000 participants (Anticipated) | Observational | 2010-03-31 | Active, not recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for estriol and Acrania
| Article | Year |
|---|---|
Combinations of maternal serum markers to predict preeclampsia, small for gestational age, and stillbirth: a systematic review.
Topics: alpha-Fetoproteins; Aneuploidy; Biomarkers; Chorionic Gonadotropin; Estriol; Female; Gestational Age | 2012 |
[Maternal serum screening for detection of fetal chromosome abnormalities].
Topics: alpha-Fetoproteins; Chorionic Gonadotropin; Chromosome Aberrations; Chromosome Disorders; Down Syndr | 1995 |
Maternal serum screening for neural tube defects and fetal chromosome abnormalities.
Topics: alpha-Fetoproteins; Chorionic Gonadotropin; Chromosome Aberrations; Chromosome Disorders; Estriol; F | 1993 |
Maternal serum screening for fetal genetic disorders.
Topics: alpha-Fetoproteins; Chorionic Gonadotropin; Chromosome Aberrations; Chromosome Disorders; Estriol; F | 1997 |
Biochemical screening for Down syndrome.
Topics: alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin, beta Subunit, Human; Down Syndrome; Estriol; | 2000 |
Biochemical screening.
Topics: alpha-Fetoproteins; Chorionic Gonadotropin; Down Syndrome; Estriol; Female; Genetic Testing; Humans; | 1990 |
1 trial available for estriol and Acrania
| Article | Year |
|---|---|
Analysis of triple test results in 27 cases of twin pregnancies.
Topics: alpha-Fetoproteins; Chorionic Gonadotropin; Down Syndrome; Estriol; Female; Gestational Age; Humans; | 1998 |
39 other studies available for estriol and Acrania
| Article | Year |
|---|---|
External Quality Assessment of Maternal Serum Levels of Alpha-Fetoprotein, Free Beta-Human Chorionic Gonadotropin, and Unconjugated Estriol in Detecting Down Syndrome and Neural Tube Defects in the Second Trimester of 87 Maternal Serum Samples, Based on 1
Topics: alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin, beta Subunit, Human; Down Syndrome; Estriol; | 2022 |
Optimization of regional median equations of prenatal screening markers for trisomy 21 in a Chinese population.
Topics: Adult; alpha-Fetoproteins; Biomarkers; China; Chorionic Gonadotropin, beta Subunit, Human; Diagnosis | 2018 |
[Predictive value of abnormal second-trimester maternal serum triple screening markers for adverse pregnancy outcomes].
Topics: Amniocentesis; Biomarkers; Chorionic Gonadotropin, beta Subunit, Human; Chromosomes, Human, Pair 18; | 2014 |
[Serum marker screening during the second trimester for prenatal diagnosis and predicting pregnancy outcome].
Topics: alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin, beta Subunit, Human; Chromosome Aberrations; | 2015 |
[Specificity of biochemical markers of pregnancy second trimester].
Topics: Adult; alpha-Fetoproteins; Biomarkers; Cross-Sectional Studies; Down Syndrome; Estriol; False Positi | 2007 |
Medication effects on midtrimester maternal serum screening.
Topics: Adult; alpha-Fetoproteins; Aneuploidy; Biomarkers; Chorionic Gonadotropin; Chromosome Disorders; Coh | 2009 |
Second trimester serum predictors of congenital heart defects in pregnancies without chromosomal or neural tube defects.
Topics: Adult; alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Chromosome Aberrations; Estriol; Fema | 2011 |
Detection rate of quadruple-marker screening determined by clinical follow-up and registry data in the statewide California program, July 2007 to February 2009.
Topics: Adult; alpha-Fetoproteins; Biomarkers; California; Chorionic Gonadotropin; Chromosome Aberrations; C | 2011 |
The impact of severe hyperemesis gravidarum on the triple test screening results.
Topics: Adult; alpha-Fetoproteins; Blood Chemical Analysis; Case-Control Studies; Chorionic Gonadotropin; Ch | 2012 |
Effect of mild hepatic or renal impairment on maternal serum screening biochemical measures.
Topics: Alanine Transaminase; alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Creatinine; Cross-Sect | 2011 |
Double-positive maternal serum screening results for down syndrome and open neural tube defects: An indicator for fetal structural or chromosomal abnormalities and adverse obstetric outcomes.
Topics: alpha-Fetoproteins; Case-Control Studies; Chorionic Gonadotropin; Chromosome Aberrations; Congenital | 2002 |
Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy.
Topics: Abortion, Spontaneous; Adult; alpha-Fetoproteins; Aneuploidy; Chorionic Gonadotropin; Down Syndrome; | 2003 |
Maternal serum screening in Ontario using the triple marker test.
Topics: alpha-Fetoproteins; Amniocentesis; Aneuploidy; Biomarkers; Chorionic Gonadotropin; Chromosomes, Huma | 2003 |
Triploidy identified through second-trimester serum screening.
Topics: Adult; alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Chromosomes, Human, Pair 18; Down Syn | 2005 |
The identification of risk of spontaneous fetal loss through second-trimester maternal serum screening.
Topics: alpha-Fetoproteins; Chorionic Gonadotropin; Chromosomes, Human, Pair 18; Down Syndrome; Estriol; Fem | 2005 |
The effects of analytical factors on second trimester risk estimations.
Topics: Adult; alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Chromosomes, Human, 16-18; Down Syndr | 2006 |
Maternal serum screening of Palestinian women in the West Bank.
Topics: Adolescent; Adult; alpha-Fetoproteins; Bias; Chi-Square Distribution; Chorionic Gonadotropin; Chromo | 2005 |
Major fetal abnormalities associated with positive screening tests for Smith-Lemli-Opitz syndrome (SLOS).
Topics: Adult; alpha-Fetoproteins; California; Chorionic Gonadotropin; Down Syndrome; Estriol; Female; Human | 2007 |
Maternal serum screening.
Topics: Algorithms; alpha-Fetoproteins; Amniocentesis; Chorionic Gonadotropin; Down Syndrome; Estriol; Femal | 1994 |
Adverse perinatal outcome in patients screen-positive for neural tube defects and fetal Down syndrome.
Topics: Adult; alpha-Fetoproteins; Amniocentesis; Chorionic Gonadotropin; Down Syndrome; Estriol; Female; Fe | 1994 |
[The triple-serum test for detection of Down syndrome and neural tube defects; the problem of a risk assessment test].
Topics: alpha-Fetoproteins; Chorionic Gonadotropin; Down Syndrome; Estriol; False Negative Reactions; False | 1993 |
[Serum screening in pregnant women for Down syndrome and open neural-tube defects; testing against the Health Council criteria for genetic screening].
Topics: alpha-Fetoproteins; Chorionic Gonadotropin; Down Syndrome; Estriol; Female; Genetic Counseling; Huma | 1996 |
A 35-year-old pregnant woman considering maternal serum screening and amniocentesis.
Topics: Adult; alpha-Fetoproteins; Amniocentesis; Biomarkers; Chorionic Gonadotropin; Chorionic Villi Sampli | 1996 |
Differences in practice patterns between obstetricians and family physicians: use of serum screening.
Topics: alpha-Fetoproteins; Chorionic Gonadotropin; Chromosome Aberrations; Estriol; Family Practice; Female | 1996 |
Antepartum screening in the office-based practice: findings from the collaborative Ambulatory Research Network.
Topics: Adolescent; Adult; alpha-Fetoproteins; Ambulatory Care; Child; Chorionic Gonadotropin; Diabetes, Ges | 1996 |
Refinements in managing maternal weight adjustment for interpreting prenatal screening results.
Topics: alpha-Fetoproteins; Body Weight; Chorionic Gonadotropin; Down Syndrome; Estriol; Female; Humans; Mat | 1996 |
Down syndrome and neural tube defect screening: the value of using gestational age by ultrasonography.
Topics: Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Down Syndrome; Estriol; Female; Gestational Age; | 1997 |
Serum triple-marker screening in in vitro fertilization and naturally conceived pregnancies.
Topics: Adult; alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Down Syndrome; Estriol; Female; Ferti | 1997 |
Combination of elevated maternal serum alpha-fetoprotein (MSAFP) and low estriol is highly predictive of anencephaly.
Topics: alpha-Fetoproteins; Anencephaly; Estriol; Female; Genetic Markers; Genetic Testing; Humans; Neural T | 1998 |
[Maternal serum screening for Down syndrome and neural tube defects].
Topics: alpha-Fetoproteins; Amniotic Fluid; Chorionic Gonadotropin; Diseases in Twins; Down Syndrome; Estrio | 1998 |
[Prenatal screening for major fetal defects by using of maternal serum markers].
Topics: Adult; alpha-Fetoproteins; Anencephaly; Biomarkers; Chorionic Gonadotropin, beta Subunit, Human; Est | 1997 |
[Maternal serum screening for congenital abnormalities and Down syndrome in Sønderjylland County. Eight years of experience].
Topics: Adult; alpha-Fetoproteins; Biomarkers; Chorionic Gonadotropin; Chromosome Aberrations; Chromosome Di | 1999 |
Participation in maternal serum screening following screen positive results in a previous pregnancy.
Topics: Adult; alpha-Fetoproteins; Anxiety; Biomarkers; Case-Control Studies; Chorionic Gonadotropin; Down S | 2000 |
Second trimester levels of maternal serum inhibin A in pregnancies affected by fetal neural tube defects.
Topics: Anencephaly; Estriol; Female; Fetal Diseases; Humans; Inhibins; Mosaicism; Neural Tube Defects; Preg | 2000 |
Participation in maternal serum screening for Down syndrome, neural tube defects, and trisomy 18 following screen-positive results in a previous pregnancy.
Topics: alpha-Fetoproteins; Anxiety; Biomarkers; Chi-Square Distribution; Chorionic Gonadotropin; Chromosome | 2000 |
Triple marker screening for trisomy 21, trisomy 18 and open neural tube defects in singleton pregnancies of native Japanese pregnant women.
Topics: Adult; alpha-Fetoproteins; Amniocentesis; Biomarkers; Chorionic Gonadotropin; Chromosomes, Human, Pa | 2000 |
Maternal serum screening for Down's syndrome, open neural tube defects and trisomy 18.
Topics: Adolescent; Adult; alpha-Fetoproteins; Amniocentesis; Chorionic Gonadotropin; Chromosomes, Human, Pa | 2001 |
Maternal serum triple analyte screening in pregnancy.
Topics: Adult; alpha-Fetoproteins; Chorionic Gonadotropin; Estriol; Female; Genetic Counseling; Humans; Neur | 2002 |
[Significance of the maternal levels of serum alpha-fetoprotein, human chorionic gonadotropin and unconjugated estriol in various congenital developmental defects in pregnancy trimester II].
Topics: alpha-Fetoproteins; Congenital Abnormalities; Estriol; Female; Humans; Maternal-Fetal Exchange; Neur | 1992 |